To look at the ability of the sGC stimulator/activators to modulate cGMP levels in SCD mice when administered immediately before TNF stimulation (0.5 μg, i.p.), we collected plasma from mice within 5 hours of administration. The gene discussed is TNF; the disease is Schnyder corneal dystrophy.